AU2002368043A8 - Multi-parameter high throughput screening assays (mphts) - Google Patents

Multi-parameter high throughput screening assays (mphts)

Info

Publication number
AU2002368043A8
AU2002368043A8 AU2002368043A AU2002368043A AU2002368043A8 AU 2002368043 A8 AU2002368043 A8 AU 2002368043A8 AU 2002368043 A AU2002368043 A AU 2002368043A AU 2002368043 A AU2002368043 A AU 2002368043A AU 2002368043 A8 AU2002368043 A8 AU 2002368043A8
Authority
AU
Australia
Prior art keywords
mphts
high throughput
screening assays
throughput screening
parameter high
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002368043A
Other versions
AU2002368043A1 (en
Inventor
Leszek Klimczak
David Evans
C Anthony Altar
Michael Palfreyman
Prithi Rajan
Derek Hook
Jeffrey A Brockman
Pascal Laeng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Psychiatric Genomics Inc
Original Assignee
Psychiatric Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Psychiatric Genomics Inc filed Critical Psychiatric Genomics Inc
Publication of AU2002368043A8 publication Critical patent/AU2002368043A8/en
Publication of AU2002368043A1 publication Critical patent/AU2002368043A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5058—Neurological cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
AU2002368043A 2001-06-18 2002-06-18 Multi-parameter high throughput screening assays (mphts) Abandoned AU2002368043A1 (en)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US29915101P 2001-06-18 2001-06-18
US60/299,151 2001-06-18
US31782801P 2001-09-07 2001-09-07
US60/317,828 2001-09-07
US32515001P 2001-09-25 2001-09-25
US60/325,150 2001-09-25
US33304701P 2001-11-14 2001-11-14
US60/333,047 2001-11-14
US34993602P 2002-01-18 2002-01-18
US60/349,936 2002-01-18
US36183402P 2002-03-04 2002-03-04
US60/361,834 2002-03-04
PCT/US2002/019457 WO2004005882A2 (en) 2001-06-18 2002-06-18 Multi-parameter high throughput screening assays (mphts)

Publications (2)

Publication Number Publication Date
AU2002368043A8 true AU2002368043A8 (en) 2004-01-23
AU2002368043A1 AU2002368043A1 (en) 2004-01-23

Family

ID=30119502

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002368043A Abandoned AU2002368043A1 (en) 2001-06-18 2002-06-18 Multi-parameter high throughput screening assays (mphts)

Country Status (2)

Country Link
AU (1) AU2002368043A1 (en)
WO (1) WO2004005882A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6765087B1 (en) 1992-08-21 2004-07-20 Vrije Universiteit Brussel Immunoglobulins devoid of light chains
DE102004016437A1 (en) * 2004-04-04 2005-10-20 Oligene Gmbh Method for detecting signatures in complex gene expression profiles
CA2565858C (en) 2004-05-11 2021-06-22 Axiogenesis Ag Assay for drug discovery based on in vitro differentiated cells
US7972793B2 (en) 2009-11-04 2011-07-05 Suregene, Llc Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype
US7985551B2 (en) 2009-11-04 2011-07-26 Suregene, Llc Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype
US7951542B2 (en) 2009-11-04 2011-05-31 Surgene, LLC Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype
US7951543B2 (en) 2009-11-04 2011-05-31 Suregene, Llc Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype
CN111826436B (en) * 2020-07-21 2022-10-04 国家烟草质量监督检验中心 Group high-throughput determination method for gene and corresponding protein expression change in hippocampal tissues in nicotine addiction, withdrawal and addiction reconstruction stages

Also Published As

Publication number Publication date
WO2004005882A2 (en) 2004-01-15
WO2004005882A3 (en) 2005-01-27
AU2002368043A1 (en) 2004-01-23

Similar Documents

Publication Publication Date Title
AU2002327791A1 (en) Multi-parameter high throughput screening assays (mphts)
AU2002230524A1 (en) Apparatus and methods for conducting assays and high throughput screening
AU2002352746A1 (en) Sample chip
AU2001263162A1 (en) Microfluidics devices and methods for high throughput screening
AU2001276908A1 (en) High throughput screening device for combinatorial chemistry
IL147637A0 (en) Sequence based screening
AU2002368043A8 (en) Multi-parameter high throughput screening assays (mphts)
AU2002249467A1 (en) Screening method
AU2002327601A1 (en) High throughput screening micro array platform
GB0116366D0 (en) High throughput assay
EP1429784A4 (en) High throughput screening assays using fatty acid synthetic enzymes
GB0108143D0 (en) High-throughput screen
IL160609A0 (en) (alpha)-haloenamine reagents
GB0028578D0 (en) Screening assays
CA96719S (en) Sorter
GB0126386D0 (en) Screening methods based on cited family proteins
GB0212652D0 (en) Screening Assay
AU2002365426A8 (en) Methods for screening osteogenic compounds
AU2002366956A8 (en) Novel parallel throughput system
AU2002354247A1 (en) Screening method
GB2428292B (en) Screening reagents
GB0007630D0 (en) Screening assays
GB0026459D0 (en) Screening assays
GB0030660D0 (en) Screening assays
AU2003227853A8 (en) Screening assay

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase